Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 941

Similar articles for PubMed (Select 9646889)

1.

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB.

Biol Psychiatry. 1998 Jul 15;44(2):77-87.

PMID:
9646889
2.

Fatty acid metabolism and its longitudinal relationship with the hypothalamic-pituitary-adrenal axis in major depression: Associations with prospective antidepressant response.

Mocking RJ, Verburg HF, Westerink AM, Assies J, Vaz FM, Koeter MW, Ruhé HG, Schene AH.

Psychoneuroendocrinology. 2015 Sep;59:1-13. doi: 10.1016/j.psyneuen.2015.04.027. Epub 2015 May 11.

PMID:
26010860
3.

Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis.

Thorlund K, Druyts E, Wu P, Balijepalli C, Keohane D, Mills E.

J Am Geriatr Soc. 2015 May;63(5):1002-9. doi: 10.1111/jgs.13395. Epub 2015 May 6.

PMID:
25945410
4.

Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression.

Hieronymus F, Emilsson JF, Nilsson S, Eriksson E.

Mol Psychiatry. 2015 Apr 28. doi: 10.1038/mp.2015.53. [Epub ahead of print]

PMID:
25917369
5.

Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.

Oakes TM, Dellva MA, Waterman K, Greenbaum M, Poppe C, Goldberger C, Ahl J, Perahia DG.

Curr Med Res Opin. 2015 Jun;31(6):1179-89. doi: 10.1185/03007995.2015.1037732. Epub 2015 May 6.

PMID:
25894953
6.

Acute fluoxetine modulates emotional processing in young adult volunteers.

Capitão LP, Murphy SE, Browning M, Cowen PJ, Harmer CJ.

Psychol Med. 2015 Apr 13:1-14. [Epub ahead of print]

PMID:
25864939
7.

Long-Term, Open-Label, Safety Study of Edivoxetine 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment.

Ball SG, Atkinson S, Sparks J, Bangs M, Goldberger C, Dubé S.

J Clin Psychopharmacol. 2015 Jun;35(3):266-72. doi: 10.1097/JCP.0000000000000302.

PMID:
25815754
8.

Serotonin syndrome with sertraline and methylphenidate in an adolescent.

Türkoğlu S.

Clin Neuropharmacol. 2015 Mar-Apr;38(2):65-6. doi: 10.1097/WNF.0000000000000075. No abstract available.

PMID:
25768857
9.

Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.

Fava GA, Gatti A, Belaise C, Guidi J, Offidani E.

Psychother Psychosom. 2015 Feb 21;84(2):72-81. [Epub ahead of print]

10.

Selective serotonin reuptake inhibitor discontinuation during pregnancy: at what risk?

Ejaz R, Leibson T, Koren G.

Can Fam Physician. 2014 Dec;60(12):1105-6. No abstract available.

11.

[Modern approaches to the synchronization of circadian rhythms in treatment of depression].

Barylnik JB, Filippova NV, Trayber LV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(11):124-8. Review. Russian.

PMID:
25629135
12.

Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.

Peselow ED, Tobia G, Karamians R, Pizano D, IsHak WW.

Psychiatry Res. 2015 Feb 28;225(3):680-6. doi: 10.1016/j.psychres.2014.11.022. Epub 2014 Nov 24.

PMID:
25496869
13.

Antidepressant-induced sexual dysfunction during treatment with fluoxetine, sertraline and trazodone; a randomized controlled trial.

Khazaie H, Rezaie L, Rezaei Payam N, Najafi F.

Gen Hosp Psychiatry. 2015 Jan-Feb;37(1):40-5. doi: 10.1016/j.genhosppsych.2014.10.010. Epub 2014 Oct 30.

PMID:
25467077
14.

Bilateral maculopathy associated with sertraline.

Ewe SY, Abell RG, Vote BJ.

Australas Psychiatry. 2014 Dec;22(6):573-5. doi: 10.1177/1039856214556327. Epub 2014 Oct 30.

PMID:
25358654
15.

Nystagmus as a discontinuation symptom after antidepressant therapy: a case report.

Blay SL.

Prim Care Companion CNS Disord. 2014;16(2). pii: PCC.13l01615. doi: 10.4088/PCC.13l01615. No abstract available.

16.

Fluoxetine-induced pancreatic beta cell dysfunction: New insight into the benefits of folic acid in the treatment of depression.

De Long NE, Hyslop JR, Raha S, Hardy DB, Holloway AC.

J Affect Disord. 2014 Sep;166:6-13. doi: 10.1016/j.jad.2014.04.063. Epub 2014 May 4.

PMID:
25012404
17.

Transient serotonin toxicity evoked by combination of electroconvulsive therapy and fluoxetine.

Klysner R, Bjerg Bendsen B, Hansen MS.

Case Rep Psychiatry. 2014;2014:162502. doi: 10.1155/2014/162502. Epub 2014 Jun 1.

18.

[Discontinuation-Emergent Signs and Symptoms Inventory--Polish translation of the discontinuation signs and symptoms checklist].

Cubała WJ, Landowski J, Springer J.

Psychiatr Pol. 2013 Jul-Aug;47(4):715-25. Polish.

PMID:
24946477
19.

Acute antidepressant response to fluoxetine and sertraline in psychiatric outpatients with psychomotor agitation.

Lane MF.

Int J Psychiatry Clin Pract. 2001;5(2):103-9. doi: 10.1080/136515001300374830.

PMID:
24931783
20.

Gains in employment status following antidepressant medication or cognitive therapy for depression.

Fournier JC, DeRubeis RJ, Amsterdam J, Shelton RC, Hollon SD.

Br J Psychiatry. 2015 Apr;206(4):332-8. doi: 10.1192/bjp.bp.113.133694. Epub 2014 Jun 12.

PMID:
24925985
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk